Related Experiment Video

Updated: Jul 2, 2026

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
07:49

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models

Published on: July 21, 2023

Can the onset of heart failure be delayed by treating diabetic cardiomyopathy?

Anna Marcinkiewicz1, Stanisław Ostrowski1, Józef Drzewoski2

  • 1Department of Cardiac Surgery, Medical University of Lodz, Pomorska 251, 92-213 Lodz, Poland.

Diabetology & Metabolic Syndrome
|April 12, 2017
PubMed

Insights

Diabetic cardiomyopathy (DC) is a heart condition linked to diabetes. Early metabolic control and addressing myocardial ischemia are key to preventing its progression to heart failure.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Diabetic cardiomyopathy (DC) is a serious complication of chronic hyperglycemia, often leading to heart failure (HF).
  • The exact pathophysiology of DC remains unclear, highlighting a gap in current understanding and treatment.
  • Myocardial ischemia is increasingly recognized as a significant factor in DC development.

Purpose of the Study:

  • To review the complexity of diabetic cardiomyopathy.
  • To summarize current knowledge on treatment strategies for patients with diabetes and coronary artery disease (CAD).
  • To emphasize the role of early diagnosis and intervention for myocardial ischemia in DC.

Main Methods:

  • Literature review focusing on pathophysiology and therapeutic strategies for DC.
  • Analysis of recent studies on the role of myocardial ischemia in DC.
  • Examination of treatment approaches including metabolic control, revascularization, and antianginal therapies.

Main Results:

  • Early metabolic control of diabetes may inhibit DC progression to HF.
  • Myocardial ischemia plays a crucial role in the development of DC.
  • Current treatments for ischemia in DC, including pharmacological and revascularization approaches, show limitations.

Conclusions:

  • Targeting the ischemic component of DC is a promising therapeutic strategy.
  • Early diagnosis and prompt revascularization of CAD in diabetic patients are critical.
  • Optimizing surgical revascularization timing, considering metabolic status, improves prognosis in DC patients.

Keywords:
CardiomyopathyCoronary artery diseaseDiabetes mellitusMyocardial revascularizationPercutaneous intervention

More Related Videos

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...